Healthcare & Life Sciences

NovImmune

Switzerland

series-c-plus

Stage

Investors

About

NovImmune develops innovative therapies focused on the modulation of the immune system to treat inflammatory and autoimmune diseases.

Funding rounds, investor list, and risk signals — unlock with a subscription.